Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drugs of Today (Barcelona, Spain : 1998)|June 30, 2012
Ipilimumab for metastatic melanomaJ Ozao-Choy, R D Carvajal, O Hamid
Journal for Immunotherapy of Cancer|November 16, 2019
Dual checkpoint inhibitor-associated eosinophilic enteritisJ Yang, S M Lagana, Y M Saenger, et al.
Sarcoma|July 17, 2015
Corrigendum to "Sarcoma Immunotherapy: Past Approaches and Future Directions"S P D'Angelo, W D Tap, G K Schwartz, et al.
Sarcoma|April 30, 2014
Sarcoma immunotherapy: past approaches and future directionsS P D'Angelo, W D Tap, G K Schwartz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2010
Phase II trial of neoadjuvant temozolomide in resectable melanoma patientsG D Shah, N D Socci, J S Gold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2009
Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumoursD S Boss, G K Schwartz, M R Middleton, et al.
British Journal of Cancer|January 9, 2023
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanomaS Piperno-Neumann, M S Carlino, V Boni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trialJ Guo, R D Carvajal, R Dummer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2026
Five-Year Survival with Tebentafusp in Metastatic Uveal MelanomaS Piperno-Neumann, P Rutkowski, J C Hassel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2022
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort studyF Dimitriou, K Namikawa, I L M Reijers, et al.
Pageof 1